How to Hire a Digital Marketing Team in 2026
22/11/2024
What is Exit Management? Benefits & Complete Process
22/11/2024
Telangana is home to over 800 Life Sciences companies with valuation of over USD 50 billion. Hyderabad, the capital city of India’s youngest State Telangana, has emerged as a leading life sciences hub in Asia housing more than 1000+ life sciences companies with a combined valued of USD 80 Bn. The state has best in class CRO providing services to pharmaceutical, biotechnology and medical devices in Country. Telangana is home to top R&D institutions such as Indian Institute of Chemical Technology. Institute of life Sciences, Centre for Stem Cell Sciences.
Telangana, in the past few years has grown leaps and bounds, especially in the life sciences sector as they received around 141 investments that amounted to about 36,000 crores in the last year alone. Additionally, the state government is also all set to introduce a dedicated LS Policy (Life Sciences policy) by the end of 2024 which will streamline processes, attract investments and drive sustainable growth across the crucial sector. This policy can help address the many new challenges in life sciences industry and ensure Telangana positions itself as an important player in the global life sciences value chain.
Noteworthy Investments leading to Employment
Some of the global giants that have made significant investments through the establishment of GCCs, and innovation centres are Cigna’s Evernorth, Amgen, Zoetis, BMS, Sanofi, HCA Healthcare and Olympus. There are also some noteworthy manufacturing and R&D investments made by Indian companies like Hetero Labs, Aragen, Laurus Labs among many others that have will be creating around 51,000 direct jobs and another 1.5 lakh indirect jobs.
On the whole the state has managed to attract 59 pharma manufacturing investments, 49 pharma formulations and R&D-related investments, 13 GCCs, nine on vaccines, biosimilars and biotech, six medical devices and healthcare related investments and three investments in Genome Valley.
Significant Investments Worth Noting
- The European Company KrKA and Laurus labs announced a joint investment of Rs 2000 crore in Genome Valley, a high technology business district located in Hyderabad, for the establishment of finished pharmaceutical products and for biopharmaceutical manufacturing in the cluster. In addition to the above, Laurus also inaugurated a State-of-the-art R&D centre that is around 250 crores. The entire investment has led to a employment potential of 2800 people.
- Vivint Pharma’s 4000 crore investment in setting up the new injectables factory will be employing around 1000 people.
- Japanese pharmaceutical major Takeda announced a partnership with Biological E to manufacture 5 Crore Dengue vaccine doses annually from Genome Valley. With this investment, Hyderabad will lead the global fight back against dengue, further cementing our position as the vaccine capital of the world.
- Sanofi’s 3600 crore GCC expansion will be creating around 2,600 new jobs in the life sciences sector.
- Rx Propellant and Terminus Group’s2000 crore investment in Genome Valley will create world class lab space infrastructure to the extent of 20 Lakh sq. ft to support innovation and R&D, which has potential to create 10,000 new jobs across multiple functions.
- Government and Thermo Fisher have partnered together to establish the country’s first scale-up biological manufacturing facility and bioprocess design centre in Genome Valley.
- Germany based Milteyni Biotec is setting up a world-class Cell and Gene Therapy facility in Genome Valley.
- Aragen – One of India’s leading CRO/CDMO announced a Rs 2000 crore expansion plan in Nacharam thereby doubling down on their strengths in Telangana and creating 1000 new jobs.
- Amgen, World’s leading biotechnology company – is establishing an innovation centre, which is one of their largest centres worldwide, in Hyderabad. This centre can accommodate 3000 people.
- Zoetis, the world’s largest animal health company inaugurated the technology and innovation centre.
- One of the world’s leading medical technology companies, Olympus headquartered in Japan, is establishing their engineering and R&D centre in Hyderabad with about 500 people.
- Medtronic’s first IT centre outside of USA, also a global health tech leader, is here in the city, with an investment of about Rs 2905 crore to establish an innovation campus.
Role of the LS Policy in positioning Telangana as a leader in Life Sciences Industry
Sources say that a dedicated Life Sciences policy will soon be rolled out and unveiled by the current chief minister Revanth Reddy. This LS policy will be able to further attract new players to Telangana during BioAsia 2025, one of the world’s leading Life Sciences and Healthcare event uniting global leaders from the industry, academia, government bodies, and regulatory bodies.
Not only will this policy attract huge investments but will drive innovation and sustainable growth to the sector.
After the Telangana global AI summit in earlier this year, the government is now kicking off sector-specific AI conferences, starting with a day-long convention on ‘Catalyst of Change: AI in Healthcare on November 18 to deliberate on the implementation of AI in the sector and unlock its potential to revolutionise healthcare.
Wrapping Up
Hyderabad’s rise as a life sciences hub is a testament to its robust ecosystem, bolstered by proactive government policies, world-class infrastructure, and a dynamic talent pool. With advancements in biotechnology, pharmaceuticals, and healthcare innovation, the city has positioned itself as a critical player in India’s life sciences landscape. Initiatives like Genome Valley, Hyderabad Pharma City, and its focus on research and development have attracted global investments and fostered local entrepreneurship.
As we move into 2025, Hyderabad’s commitment to fostering innovation and collaboration will cement its reputation as a global life sciences destination, driving economic growth, generating employment, and contributing significantly to the advancement of healthcare solutions worldwide.
Rajkumar Shanmugam
Rajkumar Shanmugam is the Head of HR at ALP Consulting, bringing over 19 years of comprehensive HR leadership experience across India and international markets. His expertise spans talent acquisition, employee relations, performance management, compliance, and HR transformation. Rajkumar has a proven track record of driving people-centric initiatives, enhancing workplace culture, and aligning HR strategy with business goals. With extensive experience in US staffing operations and global mobility, he continues to lead organizational excellence through innovation and employee engagement.
